A detailed history of J.Safra Asset Management Corp transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, J.Safra Asset Management Corp holds 583 shares of TMDX stock, worth $37,253. This represents 0.01% of its overall portfolio holdings.

Number of Shares
583
Previous 442 31.9%
Holding current value
$37,253
Previous $66,000 37.88%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$135.68 - $176.11 $19,130 - $24,831
141 Added 31.9%
583 $91,000
Q2 2024

Jul 17, 2024

BUY
$72.62 - $150.62 $27,813 - $57,687
383 Added 649.15%
442 $66,000
Q1 2024

May 09, 2024

BUY
$70.86 - $89.93 $4,180 - $5,305
59 New
59 $4,000

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.03B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track J.Safra Asset Management Corp Portfolio

Follow J.Safra Asset Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.Safra Asset Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on J.Safra Asset Management Corp with notifications on news.